These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 22250239)

  • 1. Consensus guidelines for the management of plaque psoriasis.
    Hsu S; Papp KA; Lebwohl MG; Bagel J; Blauvelt A; Duffin KC; Crowley J; Eichenfield LF; Feldman SR; Fiorentino DF; Gelfand JM; Gottlieb AB; Jacobsen C; Kalb RE; Kavanaugh A; Korman NJ; Krueger GG; Michelon MA; Morison W; Ritchlin CT; Stein Gold L; Stone SP; Strober BE; Van Voorhees AS; Weiss SC; Wanat K; Bebo BF;
    Arch Dermatol; 2012 Jan; 148(1):95-102. PubMed ID: 22250239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Psoriasis Foundation clinical consensus on disease severity.
    Pariser DM; Bagel J; Gelfand JM; Korman NJ; Ritchlin CT; Strober BE; Van Voorhees AS; Young M; Rittenberg S; Lebwohl MG; Horn EJ;
    Arch Dermatol; 2007 Feb; 143(2):239-42. PubMed ID: 17310004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis.
    Lebwohl M; Bagel J; Gelfand JM; Gladman D; Gordon KB; Hsu S; Kalb RE; Kimball AB; Korman NJ; Krueger GG; Mease P; Morison WL; Paller A; Pariser DM; Ritchlin C; Strober B; Van Voorhees A; Weinstein GD; Young M; Horn L
    J Am Acad Dermatol; 2008 Jan; 58(1):94-105. PubMed ID: 17980456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis in patients with HIV infection: from the medical board of the National Psoriasis Foundation.
    Menon K; Van Voorhees AS; Bebo BF; Gladman DD; Hsu S; Kalb RE; Lebwohl MG; Strober BE;
    J Am Acad Dermatol; 2010 Feb; 62(2):291-9. PubMed ID: 19646777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of psoriasis in patients with hepatitis C: from the Medical Board of the National Psoriasis Foundation.
    Frankel AJ; Van Voorhees AS; Hsu S; Korman NJ; Lebwohl MG; Bebo BF; Gottlieb AB;
    J Am Acad Dermatol; 2009 Dec; 61(6):1044-55. PubMed ID: 19811848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot evaluation of supra-erythemogenic phototherapy with excimer laser in the treatment of patients with moderate to severe plaque psoriasis.
    Gattu S; Pang ML; Pugashetti R; Malick F; Hong J; Bowers E; Levatter JI; Koo J
    J Dermatolog Treat; 2010 Jan; 21(1):54-60. PubMed ID: 19711219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus Conference.
    Rosmarin DM; Lebwohl M; Elewski BE; Gottlieb AB;
    J Am Acad Dermatol; 2010 May; 62(5):838-53. PubMed ID: 19932926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled study of excimer and pulsed dye lasers in the treatment of psoriasis.
    Taibjee SM; Cheung ST; Laube S; Lanigan SW
    Br J Dermatol; 2005 Nov; 153(5):960-6. PubMed ID: 16225606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A series of critically challenging case scenarios in moderate to severe psoriasis: a Delphi consensus approach.
    Strober B; Berger E; Cather J; Cohen D; Crowley JJ; Gordon KB; Gottlieb A; Horn EJ; Kavanaugh AF; Korman NJ; Krueger GG; Leonardi CL; Menter A; Schwartzman S; Sobell JM; Young M
    J Am Acad Dermatol; 2009 Jul; 61(1 Suppl 1):S1-S46. PubMed ID: 19527820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference.
    Kalb RE; Strober B; Weinstein G; Lebwohl M
    J Am Acad Dermatol; 2009 May; 60(5):824-37. PubMed ID: 19389524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the standard of care for patients with psoriasis.
    Pariser DM
    Manag Care; 2003 May; 12(5 Suppl):18-20; discussion 20-1. PubMed ID: 18567144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the 308-nm excimer laser and a 308-nm excimer lamp with 311-nm narrowband ultraviolet B in the treatment of psoriasis.
    Köllner K; Wimmershoff MB; Hintz C; Landthaler M; Hohenleutner U
    Br J Dermatol; 2005 Apr; 152(4):750-4. PubMed ID: 15840108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatments for mild-to-moderate recalcitrant plaque psoriasis: expected clinical and economic outcomes for first-line and second-line care.
    Marchetti A; Feldman SR; Kimball AB; Anderson RR; Miller LH; Martin J; An P
    Dermatol Online J; 2005 Mar; 11(1):1. PubMed ID: 15748542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric psoriasis: updates in biologic therapies.
    Sukhatme SV; Gottlieb AB
    Dermatol Ther; 2009; 22(1):34-9. PubMed ID: 19222515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etanercept in the treatment of psoriasis and psoriatic arthritis with concomitant hepatitis C virus infection: clinical and virological study in three patients.
    Zanni M; Missale G; Santilli D; Di Nuzzo S
    Eur J Dermatol; 2011; 21(4):564-7. PubMed ID: 21543290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A maintenance protocol for psoriasis plaques cleared by the 308 nm excimer laser.
    Housman TS; Pearce DJ; Feldman SR
    J Dermatolog Treat; 2004 Apr; 15(2):94-7. PubMed ID: 15204159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of moderate to severe plaque psoriasis (part I): clinical update on antitumor necrosis factor agents.
    Sobell JM; Kalb RE; Weinberg JM
    J Drugs Dermatol; 2009 Feb; 8(2):147-54. PubMed ID: 19213230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.
    Tyring S; Gordon KB; Poulin Y; Langley RG; Gottlieb AB; Dunn M; Jahreis A
    Arch Dermatol; 2007 Jun; 143(6):719-26. PubMed ID: 17576937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The National Psoriasis Foundation Psoriasis Score (NPF-PS) system versus the Psoriasis Area Severity Index (PASI) and Physician's Global Assessment (PGA): a comparison.
    Gottlieb AB; Chaudhari U; Baker DG; Perate M; Dooley LT
    J Drugs Dermatol; 2003 Jun; 2(3):260-6. PubMed ID: 12848110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in the treatment of moderately severe scalp psoriasis in Scotland - results of a survey of Scottish health professionals.
    Smith DR; Bottomley JM; Auland M; Jackson P; Sharp J
    Curr Med Res Opin; 2011 Jan; 27(1):239-49. PubMed ID: 21142837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.